NCT07331363

Brief Summary

The goal of this clinical trial is to learn if robotic ultrasound screening works as well as or better than traditional sonographer-led screening for detecting breast cancer. It will also explore how well participants follow recommended post-screening care. The main questions it aims to answer are: Does robotic ultrasound screening detect more cases of breast cancer compared to traditional sonographer-led screening? How well do participants follow up on recommended care after robotic ultrasound screening? Researchers will compare robotic ultrasound screening to traditional sonographer-led screening to see if robotic ultrasound works effectively for breast cancer screening. Participants will: Receive a breast ultrasound performed either by a robotic system or a human sonographer. Undergo follow-up management based on their BI-RADS classification.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70,000

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
7mo left

Started Dec 2025

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Dec 2025Dec 2026

Study Start

First participant enrolled

December 10, 2025

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 28, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2026

Last Updated

January 9, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 28, 2025

Last Update Submit

December 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The detection rate of breast cancer

    Number of detected ductal carcinoma in situ (DCIS) and invasive breast cancers divided by the total number of screened participants.

    After participating in the screening, the subjects will be followed up for 24 months.

Secondary Outcomes (13)

  • Cancer type

    After participating in the screening, the subjects will be followed up for 24 months.

  • The early diagnosis rate

    After participating in the screening, the subjects will be followed up for 24 months.

  • Lymph node status

    After participating in the screening, the subjects will be followed up for 24 months.

  • Breast cancer clinical stage

    After participating in the screening, the subjects will be followed up for 24 months.

  • Histological Grading of Breast Cancer

    After participating in the screening, the subjects will be followed up for 24 months.

  • +8 more secondary outcomes

Study Arms (2)

Intervention group: Using an ultrasound robot to screen the subjects

EXPERIMENTAL
Device: Screening of the subjects was conducted using an ultrasonic robot.

The subjects are scanned with traditional hand-held ultrasound.

NO INTERVENTION

The subjects are scanned with traditional hand-held ultrasound.The images are diagnosed by radiologists.

Interventions

The ultrasound robot automatically scans the breasts of subjects via its mechanical arm and generates images.The diagnosis is made based on the radiologist's interpretation of the images.

Intervention group: Using an ultrasound robot to screen the subjects

Eligibility Criteria

Age35 Years - 64 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • women aged 35-64 years
  • no history of breast cancer
  • ownership and ability to use a smartphone
  • willingness to participate in the screening program.

You may not qualify if:

  • Women who have undergone breast removal surgery;
  • Pregnant and lactating women;
  • Women who have undergone breast cancer screening within the past year;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rural health centers and community health centers

Xiantao, Hubei, 433000, China

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Xiaoxv Yin, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 28, 2025

First Posted

January 9, 2026

Study Start

December 10, 2025

Primary Completion (Estimated)

December 10, 2026

Study Completion (Estimated)

December 10, 2026

Last Updated

January 9, 2026

Record last verified: 2025-12

Locations